Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0042963 (vomiting)
 31,883 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A questionnaire survey of motion sickness occurrence on board passenger ferries has been conducted. Data were collected from 20,029 passengers on 114 voyages on 9 vessels: 6 ships, 2 hovercraft, and 1 jetfoil. Information was obtained about feelings of illness, the occurrence of vomiting, the taking of anti-seasickness tablets, the consumption of alcoholic drinks, regularity of travel by sea, age, and sex. Overall, 7% of passengers reported vomiting at some time during the journey, 21% said they felt "slightly unwell," 4% felt "quite ill," and a further 4% felt "absolutely dreadful." Both vomiting incidence and illness rating were greater in females than in males, and there was a slight decrease in sickness occurrence with increasing age. The incidence of vomiting was related to the taking of tablets and the drinking of alcohol; there were also some interaction effects with other variables. Anecdotal information from passengers is reported and consideration is given to the effects of environmental variables.
 ...
PMID:A survey of the occurrence of motion sickness amongst passengers at sea. 339 95

The occurrence of sleep troubles, recurrent abdominal pain, motion sickness, hyperactivity, dizziness, limb pain, cyclic vomiting, pseudoangine and the headache or migraine family history have been studied in 68 children migraine sufferers and compared to 68 non-headache sufferers whose ages range from 7 to 15. Data have revealed a significant predominance of those symptoms and family histories in migraine sufferers except pseudoangine which has had no significance, sleep troubles significant only in males and limb pains in females. The possibility of considering those factors as migraine risk factors is discussed.
 ...
PMID:[Risk factors in headache in children from 7 to 15]. 344 22

Episodes of emesis unaccompanied by the usual prodromal signs of motion sickness have been reported by astronauts in the space shuttle program (10). Such reports have raised the issue whether space motion sickness has different characteristics from terrestrial motion sickness. We present evidence here from parabolic flight experiments that sudden vomiting can occur in response to a provocative vestibular stimulus even when no premonitory symptoms are being experienced. Accordingly, in chronic exposure conditions, the absence of prominent signs or symptoms of motion sickness does not necessarily mean an absence of sensitization.
 ...
PMID:Sudden emesis following parabolic flight maneuvers: implications for space motion sickness. 348 69

An inflight, clinically-oriented investigation of SMS was begun on STS-4 and revealed the following: compared to motion sickness on Earth, autonomic signs are significantly different in space motion sickness (SMS) vs. motion sickness (MS) in that sweating is not present, pallor or flushing may be present, and vomiting is episodic, sudden, and brief. Nausea may be present but is more often absent. Onset ranges from minutes to hours, plateaus, and rapidly resolves in 8-72 h with 36 h as average. Postflight reactions have been mild unless deliberately provoked in the early period of re-exposure to gravity. Postflight there is a period of resistance to all forms of motion sickness. There is some evidence for individual reduction in sensitivity on repeated flights. Etiology could not be proven objectively; however, the sensitivity to angular motion, often pronounced in pitch, and theoretical considerations make an intravestibular conflict the most likely cause. Electro-oculogram (EOG), audio-evoked potentials, measurement of fluid shifts, and other studies are inconsistent with a transient vestibular hydrops or increased intracranial pressure as a cause.
 ...
PMID:Clinical characterization and etiology of space motion sickness. 349 91

Motion sickness (MS) was provoked in healthy volunteers subjected to simultaneous rotation through the vertical axis with head movements (HM). Arterial blood pressure (BP), heart rate (HR) and forearm blood flows (BF) were intermittently monitored. Forearm BF was measured by venous occluding plethysmography. Rotation at 20 rpm and cyclic HM were continued for 10 min or until the subject requested cessation of HM because of imminent emesis. There were no consistent changes in BP or HR, but marked increases in BF were observed with MS. There was an inverse correlation between duration of HM tolerance and increments in BF. Antimotion sickness medications scopolamine:d-amphetamine (0.4:5.0 mg) or promethazine:ephedrine (25:60 mg) failed to significantly increase the duration of HM; the latter mixture, however, did significantly reduce the HM-induced-hyperemic responses. Administration of naproxyn (275 or 550 mg) did not significantly alter HM duration or BF responses. These studies suggest that BF changes may be an objective index of MS susceptibility.
 ...
PMID:Pharmacological interventions for motion sickness: cardiovascular effects. 349 96

A method is proposed by which the incidence of motion sickness may be predicted from measurement of the motion exposure. The method is based on data from both field and laboratory studies involving large numbers of people and is applicable to marine and other environments where vertical oscillation occurs at frequencies below 0.5 Hz. The dependence of motion sickness on the frequency of oscillation requires the use of a weighting function between 0.1 and 0.5 Hz. The dependence of sickness on the duration of exposure is incorporated by the use of a cumulative measure of motion dose based on the product of root-mean-square (rms) acceleration magnitude and the square root of stimulus duration. The influence of population variables such as sex, age, and motion experience is discussed. The method enables separate predictions to be made of vomiting incidence and of feelings of illness. The prediction procedure, while not seeking to explain the underlying mechanisms of motion sickness occurrence, provides a generally applicable method which is simple to use and has an accuracy consistent with the experimental data on which it is based.
 ...
PMID:Prediction of the incidence of motion sickness from the magnitude, frequency, and duration of vertical oscillation. 365 26

L-sulpiride, at a dose of 4 mg/kg, essentially abolished motion-induced emesis in a group of 6 squirrel monkeys undergoing horizontal rotation at 25 rpm, a terrestrial model of space motion sickness (SMS). Extrapyramidal side effects were not observed. In the absence of the drug, the usual emetic response returned. In comparison while typical neuroleptics were also strongly anti-emetic, they produced a considerable degree of rigidity and akinesia.
 ...
PMID:The anti-emetic properties of 1-sulpiride in a ground-based model of space motion sickness. 365 84

Cats were tested for motion sickness following s.c. pretreatment with four doses of buspirone. Buspirone blocked motion sickness with an ED50 of 0.46 mg . kg-1 base. Buspirone pretreatment (4.0 mg . kg-1 base) also significantly blocked vomiting in cats later injected with 0.66 mg . kg-1 (base) s.c. of the emetic drug xylazine. The results are interpreted as showing that buspirone is acting at the vomiting center, the point of convergence for the separate mechanisms subserving chemically-induced emesis and motion sickness.
 ...
PMID:Buspirone blocks motion sickness and xylazine-induced emesis in the cat. 367 71

Gastrointestinal (Gl) symptoms in space motion sickness (SMS) are significantly different from those in ordinary motion sickness (MS). Vomiting is sudden, often unexpected, infrequent, never prolonged and usually without nausea. Inflight bowel sounds are absent in those with SMS but present after recovery and in those not affected. Recording and tabulation of sounds was the only technique that could be used as a measure of motility during spaceflight operations. There were 17 subjects, 6 unaffected by SMS, who made ambulatory recordings pre- and inflight. With one exception, all those affected had sharply reduced sounds while those unaffected had increases or moderate reductions. The mechanism of vomiting in SMS appears to be secondary to this ileus in contrast to vomiting in ordinary MS, where the emesis center is thought to be directly triggered by the vestibular system. This ileus appears to be the only consistent and reliable indicator for SMS to date.
 ...
PMID:Gastrointestinal motility in space motion sickness. 367 84

Motion-induced vomiting was studied in cats exposed to vertical sinusoidal oscillation on a spring-suspended platform. Two groups of five cats each, namely, motion-untested and motion sickness-susceptible, were subjected to chronic ablation of the area postrema. Motion sickness occurred postoperatively in all the previously untested cats, and in four of the five previously susceptible cats. Statistical comparison with normal cats indicated that the operated cats were significantly more susceptible to motion sickness. The manifest loss of susceptibility in one cat with a lesion is attributed to excessive peripostremal damage. It is concluded from these results that the area postrema is not an essential link in the reflex arc of motion-induced vomiting.
 ...
PMID:Motion sickness reflex arc bypasses the area postrema in cats. 370 44


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>